Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer
Verhoeff, S. R., van de Donk, P. P., Aarntzen, E. H. J. G., Oosting, S. F., Brouwers, A. H., Miedema, I. H. C., Voortman, J., Menke-van der Houven van Oordt, W. C., Boellaard, R., Vriens, D., Slingerland, M., Hermsen, R., van Engen-van Grunsven, I., Heskamp, S. & van Herpen, C. M. L., 5-mei-2022, (E-pub ahead of print) In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine.Onderzoeksoutput › Academic › peer review
-
A Randomized Ph2 Study of MEDI0680 in Combination With Durvalumab vs. Nivolumab Monotherapy in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Voss, M. H., Azad, A. A., Hansen, A. R., Gray, J. E., Welsh, S. J., Song, X., Kuziora, M., Meinecke, L., Blando, J., Achour, I., Wang, Y., Walcott, F. & Oosting, S. F., 2022, (E-pub ahead of print) In: Clinical Cancer Research.Onderzoeksoutput › Academic › peer review
Open AccessBestand8 Downloads (Pure) -
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
Nakauma-González, J. A., Rijnders, M., van Riet, J., van der Heijden, M. S., Voortman, J., Cuppen, E., Mehra, N., van Wilpe, S., Oosting, S. F., Rijstenberg, L. L., Westgeest, H. M., Zwarthoff, E. C., de Wit, R., van der Veldt, A. A. M., van de Werken, H. J. G., Lolkema, M. P. J. & Boormans, J. L., 24-jan-2022, (E-pub ahead of print) In: European Urology.Onderzoeksoutput › Academic › peer review
Open AccessBestand5 Downloads (Pure) -
Disadvantaged Subgroups Within the Global Head and Neck Cancer Population: How Can We Optimize Care?
Corry, J., Ng, W. T., Ma, S. J., Singh, A. K., de Graeff, P. & Oosting, S. F., apr-2022, In: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 42, blz. 1-10 10 blz.Onderzoeksoutput › Academic › peer review
-
Eligibility criteria for programmed death receptor 1 inhibitors vs. real-world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck
Leus, A. J. G., Horváth, B., Terra, J. B., Diercks, G. F. H., Plaat, B. E. C., Oosting, S. F. & Rácz, E., feb-2022, In: BRITISH JOURNAL OF DERMATOLOGY. 186, 2, blz. 371-372 2 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand10 Downloads (Pure)
Activiteiten
-
Immuuntherapie voor niercelcarcinoom: wat en wanneer?
Sjoukje Oosting (Speaker)
13-nov-2020Activiteit: Professional or public presentation › Professional
-
Supervising PhD student Pim van de Donk
Liesbeth de Vries (Supervisor), Sjoukje Oosting (Co-supervisor) & Anthonie van der Wekken (Co-supervisor)
1-jan-2020 → …Activiteit: Supervision and examination of PhD students of the UG › Academic
-
Angiogenese remming en immunotherapie bij niercelcarcinoom
Sjoukje Oosting (Speaker)
1-jul-2020Activiteit: Professional or public presentation › Professional
-
Supervision of PhD student Marloes Peters
Ido Kema (Supervisor), Annemiek Walenkamp (Co-supervisor), Sjoukje Oosting (Co-supervisor) & Coby Meijer (Co-supervisor)
26-okt-2020Activiteit: Supervision and examination of PhD students of the UG › Academic
-
European Society for Medical Oncology (ESMO) , Lugano , Switzerland. (Externe Organisatie)
S. F. Oosting (Member)
2019Activiteit: Membership › Academic
Knipsels
-
Vaccino Covid: nei pazienti in chemioterapia buona risposta anticorpale
14/11/2021
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Effecten van systemische behandeling voor solide tumoren op werkzaamheid en veiligheid van mRNA-1273 COVID-19 vaccin
10/11/2021
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Many Patients With Solid Tumors Mount an Adequate Response to SARS–CoV-2 Vaccine, Dutch Study Reports
10/11/2021
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
New Combos of Old Drugs Improve Survival in Patients With Prostate Cancer: Day 3 of the European Society for Medical Oncology’s 2021 Congress
05/10/2021
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Most Solid Tumor Patients Have ‘Adequate’ Response to COVID-19 Vaccination, Regardless of Treatment
04/10/2021
1 item van Media-aandacht
Pers / media: Expert Comment › Popular